AVDL, NGM

Avadel Pharmaceuticals plc (AVDL)

Price (as of October 26)

5.85USD

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

AMYT

Amryt Pharma plc

-0.05

ENDP

Endo International plc

-0.04

DERM

Journey Medical Corporation

-0.04

AMPH

Amphastar Pharmaceuticals, Inc.

-0.04

EOLS

Evolus, Inc.

-0.03

AZN.L

AstraZeneca PLC

-0.02

HEXO

HEXO Corp.

-0.01

CRON

Cronos Group Inc.

-0.01

AZN

AstraZeneca PLC

-0.01

CRDL

Cardiol Therapeutics Inc.

-0.01

Show more

Highest within Industry

Symbol Correlation

ALVO

Alvotech

0.21

ACB

Aurora Cannabis Inc.

0.11

AYTU

Aytu BioPharma, Inc.

0.08

AKAN

Akanda Corp.

0.07

FLGC

Flora Growth Corp.

0.07

ACRX

AcelRx Pharmaceuticals, Inc.

0.06

ATNX

Athenex, Inc.

0.04

ACOR

Acorda Therapeutics, Inc.

0.04

ANIP

ANI Pharmaceuticals, Inc.

0.04

AQST

Aquestive Therapeutics, Inc.

0.04

Show more

Profile

Sector:
Healthcare
Industry:
Drug Manufacturers

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.